Rialto Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
3,295
+7
+0.2% +$2.4K 0.24% 66
2026
Q1
$1.16M Sell
3,288
-19
-0.6% -$6.77K 0.26% 63
2025
Q4
$1.08M Buy
3,307
+340
+11% +$108K 0.26% 66
2025
Q3
$837K Buy
2,967
+6
+0.2% +$1.74K 0.22% 75
2025
Q2
$827K Buy
2,961
+2
+0.1% +$567 0.23% 75
2025
Q1
$922K Buy
2,959
+7
+0.2% +$2.07K 0.29% 71
2024
Q4
$769K Buy
+2,952
New +$876K 0.25% 69

Other funds holding AMGN

Rialto Wealth Management's AMGN Position: Q2 2026 in Review

Rialto Wealth Management increased its Amgen (AMGN) stake by 0.21% in Q2 2026, buying an estimated $2.4K and bringing the position to 3,295 shares worth $1.19M. The position accounts for 0.24% of the portfolio, ranked #66.

Rialto Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Rialto Wealth Management held 3,295 shares of Amgen worth $1.19M as of Q2 2026.
  • Rialto Wealth Management bought 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 0.24% of Rialto Wealth Management's portfolio in Q2 2026, its #66 holding.
  • Rialto Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.